Clinical Trial Update: LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant [Phase 4]

View source ↗

Summary

An update on a Phase 4 study comparing two doses of ciclosporine in patients receiving de novo cardiac transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Transplantation

Drugs mentioned

• Ciclosporine (Cyclosporine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cardiac Transplantion | Phase 4 | Status: UNKNOWN